logo
logo

Enthera Pharmaceuticals Extends Series A Financing, Raising a Total Of €35m

Enthera Pharmaceuticals Extends Series A Financing, Raising a Total Of €35m

01/28/21, 9:04 AM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/IT.svgmilan
Money raised
€35 million
Round Type
series a
Enthera Pharmaceuticals (“Enthera”), a biotech company developing disease-modifying biologics to transform the therapeutic paradigm of specific autoimmune conditions by re-establishing stem cell capabilities in a non-traditional way, today announces the final closing of its Series A financing, with a total financing of €35m.

Company Info

Company
Enthera
Location
milan, lombardy, italy
Additional Info
Enthera Srl is a biotech company developing first-in-class biologics to transform the treatment paradigm of specific autoimmune conditions by re-establishing stem cell capabilities in a non-traditional way. The Company’s primary target indications are type 1 diabetes (T1D) and inflammatory bowel disease (IBD).